Pear Therapeutics was one of the most notable companies in digital therapeutics and its downfall could be an ominous sign for other industry players. “I worry it’s a signal for the immediate future of digital therapeutics,” said Dr. Rishad Usmani, founder of Healthtech Investors.  Usmani has mentored and consulted founders in the digital therapeutics industry on […]

A common amino acid, glycine, can signal the brain to slow down, likely an operational variable in major depression, anxiety and other mood disorders, scientists at the Wertheim UF Scripps Institute for Biomedical Innovation & Technology discovered recently. The discovery, first reported by Science, improves understanding of the biological causes of major depressive disorder (MDD) and could speed […]

Developing new drugs is rarely as simple as spending an amount of money and coming out with an effective and marketable product on a set schedule. Artificial intelligence can help — sifting through millions of molecular combinations and existing drugs to find the few that can be repurposed or redesigned to cure.